Data sourced from ClinicalTrials.gov (NIH registry) Updated weekly IRB-supervised studies only
Home/NE/Lincoln
Updated July 2026 from ClinicalTrials.gov

Paid Clinical Trials in Lincoln, NE

Studies commonly pay $75 to $4,500 per completed study

161 clinical trials are currently recruiting participants within 30 miles of Lincoln. Listings below come straight from the official NIH registry, alongside the area's top-rated research centers with real Google reviews.

161studies recruiting
9+research centers nearby
4condition categories
Live from the NIH registry

Studies recruiting near Lincoln right now

Top 25 of 161 recruiting studies, sorted by proximity — each links to its official registry page

A Study to Evaluate AZD7760 Safety and Pharmacokinetics in Healthy Adults (Phase I) and Adults With End-stage Kidney Disease on Hemodialysis With a Central Venous Catheter (Phase IIa)

Staphylococcus Aureus Phase 1, Phase 2 Interventional 231 participants sought
Research Site — Lincoln, Nebraska (0.9 mi) · Sponsor: AstraZeneca
See eligibility & contact on ClinicalTrials.gov (NCT06749457)

Testing the Use of Combination Therapy in Adult Patients With Newly Diagnosed Multiple Myeloma, the EQUATE Trial

Plasma Cell Myeloma, RISS Stage I Plasma Cell Myeloma Phase 3 Interventional 1,450 participants sought
Saint Elizabeth Regional Medical Center — Lincoln, Nebraska (0.9 mi) · Sponsor: ECOG-ACRIN Cancer Research Group
See eligibility & contact on ClinicalTrials.gov (NCT04566328)

A Study of Pasritamig With Docetaxel Versus Docetaxel in Participants With Metastatic Castration-Resistant Prostate Cancer

Prostatic Neoplasms, Castration-Resistant Phase 3 Interventional 800 participants sought
NHO Revive Research Institute, LLC — Lincoln, Nebraska (0.9 mi) · Sponsor: Janssen Research & Development, LLC
See eligibility & contact on ClinicalTrials.gov (NCT07225946)

A Study to Assess Adverse Events and How Intravenously (IV) Infused Telisotuzumab Vedotin (ABBV-399) Moves Through the Body as a Monotherapy in Adult Participants With Previously Treated Non-Squamous Non-Small Cell Lung Cancer (NSCLC)

Non-Small Cell Lung Cancer Phase 2 Interventional 150 participants sought
Nebraska Hematology-Oncology /ID# 272970 — Lincoln, Nebraska (0.9 mi) · Sponsor: AbbVie
See eligibility & contact on ClinicalTrials.gov (NCT06568939)

A Study of Camizestrant in ER+/HER2- Early Breast Cancer After at Least 2 Years of Standard Adjuvant Endocrine Therapy

Breast Cancer, Early Breast Cancer Phase 3 Interventional 4,300 participants sought
Research Site — Lincoln, Nebraska (0.9 mi) · Sponsor: AstraZeneca
See eligibility & contact on ClinicalTrials.gov (NCT05774951)

A Phase III, Open Label, Randomized, Controlled Study of VBI-S in the Treatment of Hypovolemia in Patients With Septic Shock (VBI-S-02)

Septic Shock, Sepsis Phase 3 Interventional 46 participants sought
Bryan Medical Center — Lincoln, Nebraska (0.9 mi) · Sponsor: Vivacelle Bio
See eligibility & contact on ClinicalTrials.gov (NCT06072430)

Evaluation of Enhanced Lithotripsy System (ELS) in the Treatment of Urinary Stones, A Pivotal Trial

Kidney Calculi; Ureteral Calculi N/A Interventional 101 participants sought
Nebraska Urology — Lincoln, Nebraska (0.9 mi) · Sponsor: Avvio Medical
See eligibility & contact on ClinicalTrials.gov (NCT06942949)

Study of Bet v1 Antibodies Effect on Eye Allergy Symptoms in Adolescents and Adults With Birch Pollen Allergy

Allergic Conjunctivitis Phase 3 Interventional 350 participants sought
Somnos Clinical Research — Lincoln, Nebraska (0.9 mi) · Sponsor: Regeneron Pharmaceuticals
See eligibility & contact on ClinicalTrials.gov (NCT07309432)

De-Escalation of Breast Radiation Trial for Hormone Sensitive, HER-2 Negative, Oncotype Recurrence Score Less Than or Equal to 18 Breast Cancer (DEBRA)

Stage I Breast Cancer Phase 3 Interventional 1,670 participants sought
Cancer Partners of Nebraska — Lincoln, Nebraska (0.9 mi) · Sponsor: NRG Oncology
See eligibility & contact on ClinicalTrials.gov (NCT04852887)

Cognitive Training for Cancer Related Cognitive Impairment in Breast Cancer Survivors

Breast Cancer, Cognitive Impairments N/A Interventional 386 participants sought
Saint Elizabeth Regional Medical Center — Lincoln, Nebraska (0.9 mi) · Sponsor: NRG Oncology
See eligibility & contact on ClinicalTrials.gov (NCT05896189)

Efficacy, Safety, and Tolerability of NBI-1065890 Versus Placebo in Adults With Tardive Dyskinesia

Tardive Dyskinesia Phase 2 Interventional 100 participants sought
Neurocrine Clinical Site — Lincoln, Nebraska (0.9 mi) · Sponsor: Neurocrine Biosciences
See eligibility & contact on ClinicalTrials.gov (NCT07365462)

Vismodegib, FAK Inhibitor GSK2256098, Capivasertib, and Abemaciclib in Treating Patients With Progressive Meningiomas

Intracranial Meningioma, Recurrent Meningioma Phase 2 Interventional 124 participants sought
Saint Elizabeth Regional Medical Center — Lincoln, Nebraska (0.9 mi) · Sponsor: Alliance for Clinical Trials in Oncology
See eligibility & contact on ClinicalTrials.gov (NCT02523014)

A Study to Learn About the Study Medicine Called PF-07328948 in Adults With Heart Failure (BRANCH-HF)

Heart Failure Phase 2 Interventional 620 participants sought
Velocity Clinical Research, Lincoln, Pioneer Heart Institute — Lincoln, Nebraska (0.9 mi) · Sponsor: Pfizer
See eligibility & contact on ClinicalTrials.gov (NCT06991257)

Safety, Tolerability and Pharmacokinetics of Lumateperone in Pediatric Patients With Autism Spectrum Disorder

Autism Spectrum Disorder Phase 1 Interventional 26 participants sought
Clinical Site 5 — Lincoln, Nebraska (0.9 mi) · Sponsor: Intra-Cellular Therapies, Inc.
See eligibility & contact on ClinicalTrials.gov (NCT06557902)

A Study of ORX489 in Healthy Adult Participants, Aged 18 to 60 Years

Healthy Adult Male and Female Volunteers Phase 1 Interventional 212 participants sought
Celerion — Lincoln, Nebraska (0.9 mi) · Sponsor: Centessa Pharmaceuticals (UK) Limited
See eligibility & contact on ClinicalTrials.gov (NCT07413666)

Testing the Addition of a Type of Drug Called Immunotherapy to the Usual Chemotherapy Treatment for Non-small Cell Lung Cancer, an ALCHEMIST Treatment Trial (Chemo-IO [ACCIO])

Lung Non-Small Cell Carcinoma, Lung Non-Small Cell Squamous Carcinoma Phase 3 Interventional 1,210 participants sought
Saint Elizabeth Regional Medical Center — Lincoln, Nebraska (0.9 mi) · Sponsor: National Cancer Institute (NCI)
See eligibility & contact on ClinicalTrials.gov (NCT04267848)

A Study of Elacestrant Versus Standard Endocrine Therapy in Women and Men With ER+,HER2-, Early Breast Cancer With High Risk of Recurrence

Breast Cancer Phase 3 Interventional 4,220 participants sought
NHO Revive Research Institute LLC — Lincoln, Nebraska (0.9 mi) · Sponsor: Stemline Therapeutics, Inc.
See eligibility & contact on ClinicalTrials.gov (NCT06492616)

Lung-MAP: A Master Screening Protocol for Previously-Treated Non-Small Cell Lung Cancer

Previously Treated Non-Small Cell Lung Cancer Phase 2, Phase 3 Interventional 10,000 participants sought
Nebraska Hematology and Oncology — Lincoln, Nebraska (0.9 mi) · Sponsor: SWOG Cancer Research Network
See eligibility & contact on ClinicalTrials.gov (NCT03851445)

Multicenter Study of Lumateperone for the Treatment of Irritability Associated With Autism Spectrum Disorder (ASD) in Pediatric Patients

Irritability Associated With Autism Spectrum Disorder Phase 3 Interventional 160 participants sought
Alivation Research LLC — Lincoln, Nebraska (0.9 mi) · Sponsor: Intra-Cellular Therapies, Inc.
See eligibility & contact on ClinicalTrials.gov (NCT06706674)

Collecting Blood Samples From Patients With and Without Cancer to Evaluate Tests for Early Cancer Detection

Multiple conditions N/A Observational 2,000 participants sought
Saint Elizabeth Regional Medical Center — Lincoln, Nebraska (0.9 mi) · Sponsor: Alliance for Clinical Trials in Oncology
See eligibility & contact on ClinicalTrials.gov (NCT05334069)

MagnetisMM-32: A Study to Learn About the Study Medicine Called Elranatamab in People With Multiple Myeloma (MM) That Has Come Back After Taking Other Treatments (Including Prior Treatment With an Anti-CD38 Antibody and Lenalidomide)

Multiple Myeloma Phase 3 Interventional 492 participants sought
Bryan Medical Center — Lincoln, Nebraska (0.9 mi) · Sponsor: Pfizer
See eligibility & contact on ClinicalTrials.gov (NCT06152575)
Google-rated

Top-rated research centers in Lincoln

Dedicated clinical research sites near you — with their real Google ratings, reviews and contact details

Celerion

★ 3.5
621 Rose St, Lincoln, NE 68502
(402) 476-2811
"I enjoyed doing a study here, the facility is huge and clean. Most of the staff are warm and friendly some not so much but I just chalked it up to th…"
— viola simms, 5★

Velocity Clinical Research

★ 4.4
4600 Valley Rd, Lincoln, NE 68510
(531) 530-2800
"Nice staff and knowledgeable doctors"
— Lionheart The Great, 5★

UNL Center for Brain, Biology, and Behavior (CB3)

★ 3.0
Stadium East, 1100 T St Suite C89, Lincoln, NE 68588
"Tell others about your experience"
— P Dot, 1★

Be Well Clinical Studies

★ 4.9
5800 Hidcote Dr #103, Lincoln, NE 68516
(402) 937-9392
"Just wonderful people. Very efficient and easy to work with. Excellent experience."
— Prashant Nadkarni, 5★

The NL3 Wang lab

4075 E Campus Loop #101X, Lincoln, NE 68583
(402) 472-0106

UNL Quantitative Life Sciences Initiative

Prem Paul Research Center at Whittier School, 2200 Vine St Ste 230, Lincoln, NE 68503
(402) 472-2512

NHO Revive Research Institute, LLC

4004 Pioneer Woods Dr, Lincoln, NE 68506
(248) 721-9539

UNL Research Compliance Services

Prem S. Paul Research Center at Whittier School, 2200 Vine St Ste 275, Lincoln, NE 68503
(402) 472-6965

Lincoln Medical Education

★ 4.7
4600 Valley Rd, Lincoln, NE 68510
(402) 483-4571
"Great place for the kids to play and learn something too!"
— Bonnie Collins, 5★

Clinical trials in Lincoln: what's recruiting

The Lincoln area currently has 161 studies open to new participants, according to the ClinicalTrials.gov registry maintained by the U.S. National Institutes of Health. Among the studies closest to Lincoln, the most active research areas are:

  • Cancer & Oncology11 studies
  • Liver & Kidney2 studies
  • Diabetes & Metabolism1 studies
  • Heart & Vascular1 studies

Every listing shows the study phase, the recruiting site and its distance from Lincoln, and links to the official registry page where eligibility criteria and study contacts are published. Compensation is set by each sponsor: industry surveys report typical payments of $75 to $4,500 per completed study, with short observational studies at the low end and multi-visit or overnight Phase 1 studies at the high end.

How to enroll in a paid study in Lincoln

Start with a study whose condition matches your profile — or a healthy-volunteer study if you have no diagnosis. Contact the research site through the registry page, complete a short phone screen, then attend an in-person screening visit. If you qualify, the study team walks you through the informed consent document, which details every procedure, risk and payment before you commit. You can withdraw at any point, and enrollment is always free.

Lincoln participants can also register with the dedicated research centers listed above — many maintain volunteer databases and call when a matching study opens — or sign up for our email alert below to hear when a new study starts recruiting within 30 miles of your ZIP code.

Frequently asked questions

How much do paid clinical trials in Lincoln pay?
Compensation varies by study length, procedures and overnight stays. Industry surveys report typical payments from $75 to $4,500 per completed study, with simple observational studies at the low end and multi-week inpatient Phase 1 studies at the high end. Each listing's study team will confirm the exact amount before you enroll.
Do I need to be sick to join a clinical trial in Lincoln?
No. Many studies recruit healthy volunteers, especially early-phase studies run at dedicated research centers. Others need participants diagnosed with a specific condition. Every trial lists its eligibility criteria — age range, condition, medications — and the study team screens you before enrollment.
Are clinical trials in Lincoln safe?
Every trial on this page is registered on ClinicalTrials.gov, the official NIH registry, and is overseen by an Institutional Review Board (IRB). Before joining you receive an informed consent document detailing procedures, risks and compensation. Participation is voluntary and you can withdraw at any time.
Is compensation for clinical trials taxable?
In the U.S., clinical trial compensation is generally considered taxable income, and research sites may issue a 1099 form for payments above $600 in a year. Reimbursements for travel or meals are typically treated differently. Consult a tax professional for your situation.
How often do new paid studies open in Lincoln?
Constantly — trials open and close enrollment every week. This page is refreshed weekly from the NIH registry. Join the email alert to be notified when a new study opens within 30 miles of Lincoln.

Paid clinical trials near Lincoln

Other metros within reach

Omaha, NE597 Topeka, KS110 Kansas City, KS1,011 Olathe, KS1,006 Kansas City, MO1,000 Sioux Falls, SD266 Overland Park, KS999 Des Moines, IA226

More of NE

Omaha597

New paid studies open every week

Get an email when a new clinical trial starts recruiting within 30 miles of your ZIP code. No spam — only real studies from the NIH registry.

By subscribing you agree to receive study alert emails. Unsubscribe anytime in one click.

Get free trial alerts